Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-034829

Director acquired 8,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Erck Stanley C · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-11-28 Exercise or conversion : show line 1 in the form +8,333 $1.49 $12,416 48,333 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-11-28 Exercise or conversion : show line 2 in the form Non-Qualified Stock Option −8,333 0 D
Loading xslF345X03/form4.xml…